Related Experiment Video
Updated: Aug 7, 2026
Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
Evaluation of comorbidity indices for inpatient mortality prediction models
1Departamento de Administração e Planejamento em Saúde, Escola Nacional de Saúde Pública Sérgio Arouca, Rio de Janeiro/RJ 21042-210, Brazil. martins@ensp.fiocruz.br
Insights
A revised Charlson Comorbidity Index (CCI) and a new index showed improved mortality prediction in Brazil. However, the gains were modest, with age and primary diagnosis remaining key predictors.
Area of Science:
- Health Services Research
- Epidemiology
- Biostatistics
Background:
- Comorbidity indices are crucial for predicting patient outcomes.
- The original Charlson Comorbidity Index (CCI) requires validation and potential updates for diverse populations.
- Assessing the impact of diagnostic information quantity on predictive accuracy is essential.
Purpose of the Study:
- To compare the predictive capacity of the original CCI, a revised CCI, and a novel index in a Brazilian cohort.
- To evaluate how the number of recorded comorbidities influences the predictive power of these indices.
- To identify key predictors of inpatient mortality in the studied population.
Main Methods:
- Retrospective study in Ribeirão Preto, Brazil (1996-1998).
- Inclusion of patients with principal diagnoses of respiratory and circulatory diseases.
- Comparative analysis of the predictive performance (C statistic) of different comorbidity indices.
Main Results:
- The revised CCI and the new index demonstrated increased mortality prediction compared to the original CCI (C statistics: 0.74 and 0.76 vs. 0.72).
- Incorporating more diagnostic information, particularly a second secondary diagnosis, enhanced the predictive capacity of all indices.
- Despite improvements, the overall increase in predictive power was considered weak.
Conclusions:
- Empirically developed comorbidity indices may offer advantages, but predictive gains are marginal.
- Age and the principal diagnosis remain the most significant predictors of inpatient mortality.
- Further research may be needed to refine comorbidity assessment for Brazilian healthcare settings.
Background And Objectives:
The objectives of the current study were: to compare the predictive capacity of the original Charlson comorbidity index (CCI), the CCI with new assigned diagnostic codes and estimated weights, and a new developed comorbidity index in a Brazilian population; and to study the effect of the number of comorbidity diseases recorded on the predictive capacity of the comorbidity indices.
Materials And Methods:
The study was limited to the Ribeirão Preto region in the State of São Paulo, Brazil, from January 1996 to December 1998. We included only admissions in which the principal diagnoses were respiratory and circulatory diseases.
Results:
Evaluation of the CCI indicates that revision of the clinical conditions studied by Charlson, as well as their weights, increased mortality model predictive capacity. The C statistic was 0.72 for the original CCI, and increased to 0.74 for the CCI with new weights and 0.76 for the new index. The C statistic increases in all the comorbidity indices with the utilization of more diagnostic information. This impact is greater when a second secondary diagnosis is added.
Conclusions:
The results of the validity analysis for comorbidity indices favor the utilization of empirically developed indices. However, the increase in predictive capacity was weak. In addition, age and principal diagnosis are the most important predictors of inpatient mortality.
